Shafat Ali Selected Research

Shafat Ali Research Topics

Disease

8	Neoplasms (Cancer) 11/2023 - 01/2014
4	Leprosy (Hansen's Disease) 02/2014 - 07/2010
2	Hypertension (High Blood Pressure) 10/2022 - 06/2022
2	Carcinoma (Carcinomatosis) 10/2021 - 11/2020
2	Habitual Abortion (Recurrent Miscarriage) 10/2020 - 03/2020
2	Infections 10/2020 - 02/2014
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2014
1	Albuminuria 10/2022
1	Ischemia 10/2022
1	Pre-Eclampsia (Preeclampsia) 10/2022
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2022
1	Abdominal Obesity 06/2022
1	Colonic Neoplasms (Colon Cancer) 01/2021
1	COVID-19 10/2020
1	Hypoprothrombinemias (Prothrombin Deficiency) 10/2020
1	Rubella (German Measles) 10/2020
1	Protein S Deficiency (Deficiency, Protein S) 10/2020
1	Carcinogenesis 01/2020
1	Genomic Instability 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Necrosis 02/2014

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 05/2023 - 10/2011
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 02/2014
2	Transforming Growth Factor-beta Type II ReceptorIBA 02/2014 - 10/2011
1	Monoclonal AntibodiesIBA 11/2023
1	LigandsIBA 11/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2023
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2022
1	salicylhydroxamic acid (SHAM)IBA 10/2022
1	KynurenineIBA 10/2022
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2022
1	Drinking WaterIBA 10/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	jervineIBA 10/2021
1	astragaloside AIBA 10/2021
1	MelatoninIBA 10/2021
1	LY-2157299IBA 10/2021
1	salvinIBA 01/2021
1	CateninsIBA 01/2021
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021
1	PhytochemicalsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	CurcuminIBA 01/2021
1	ResveratrolIBA 01/2021
1	Polysaccharides (Glycans)IBA 11/2020
1	AntioxidantsIBA 11/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2020
1	Cholecalciferol (Vitamin D3)FDA Link 10/2020
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 10/2020
1	factor V LeidenIBA 10/2020
1	Peptide Hydrolases (Proteases)FDA Link 10/2020
1	Progesterone FDA LinkGeneric 10/2020
1	ProlactinIBA 10/2020
1	Thrombin FDA Link 10/2020
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 10/2020
1	Thyroxine (Levothyroxine)FDA LinkGeneric 10/2020
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 10/2020
1	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 10/2020
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2020
1	Antiphospholipid AntibodiesIBA 10/2020
1	Anticardiolipin AntibodiesIBA 10/2020
1	Protein SIBA 10/2020
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 10/2020
1	AntibodiesIBA 10/2020
1	Antinuclear AntibodiesIBA 10/2020
1	Blood Glucose (Blood Sugar)IBA 10/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Exonucleases (3' 5' Exonuclease)IBA 01/2020
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2020
1	AndrogensIBA 01/2020
1	Sirtuin 1IBA 01/2016
1	Interleukin-6 (Interleukin 6)IBA 02/2014
1	InterleukinsIBA 02/2014
1	Untranslated Regions (Untranslated Region)IBA 01/2014
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2014
1	P-2 (P 2)IBA 01/2013
1	AntigensIBA 01/2013
1	Transforming Growth Factor-beta Type I ReceptorIBA 10/2011
1	Interleukin-13IBA 10/2011
1	HLA-DRB1 Chains (HLA DRB1)IBA 07/2010
1	HLA-DQA1 antigen (HLA DQA1)IBA 07/2010
1	Toll-Like Receptor 1IBA 07/2010

Therapy/Procedure

2	Therapeutics 11/2023 - 10/2021
1	Drug Therapy (Chemotherapy) 11/2022
1	Immunomodulation 10/2021
1	Immunotherapy 10/2021